Dallas, Texas (PRWEB) April 02, 2014
The proteomics market showcases a high-growth potential, owing to the increasing demand for proteomics techniques in drug discovery and diagnostics applications. The availability of research funds across the globe, which increases the purchasing power of research and academic institutes, is also playing a pivotal role in the growth of the proteomics market. However, various other factors such as the sequestration cuts in the U.S.; disconnect between biomarker discovery and approval by regulatory authorities; and the need for expensive, well-qualified, and mandatory training required for better utilization of proteomics tools represents a significant challenge for the market growth during the forecast period of 2013 to 2018.
Complete report available @ http://www.rnrmarketresearch.com/proteomics-market-protein-microarray-mass-spectrometry-nmr-spectroscopy-chromatography-electrophoresis-surface-plasmon-resonance-protein-fractionation-x-ray-crystallography-immunoassay-ins-market-report.html .
Besides the structural market drivers, there are strong geographic drivers for the growth of the proteomics market. The economic situation and cost-containment issues have diverted the attention of proteomics research-based companies from North America and Europe to emerging markets such as China and India. Major companies are establishing their subsidiaries in these regions and are investing for building a stronger foothold in these countries. The Asian region forms one of the most promising proteomics markets in the world. Developing countries such as China and India are expected to grow at relatively higher growth rates, owing to the rising awareness about the benefits of personalized medicine, and growing research base, backed by the availability of government and private funding for research.
Personalized medicine is one of the niche markets, and has witnessed a significant growth rate in the past few years. As a result of the rising demand for proteomics technology in personalized medicine and biomarker profiling particularly in cancer research, the proteomics market has witnessed growth in the past few years. Thus, further growth in the personalized medicine market is reckoned as one of the strongest growth drivers for the global proteomics market.
Reasons to Buy the Report:
This report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms in garnering greater market shares. Firms purchasing the report could use any one or a combination of the below mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for increasing their market shares.
Order a copy of this report at http://www.rnrmarketresearch.com/contacts/purchase?rname=59992 .
The report provides insights on the following pointers:
11 Company Profiles (Overview, Financials, Products & Services, Strategy, & Developments)
11.1 Thermo Fisher Scientific Inc.
11.2 Agilent Technologies, Inc.
11.3 Bio-Rad Laboratories, Inc.
11.4 Luminex Corporation
11.5 Danaher Corporation
11.6 GE Healthcare
11.7 Waters Corporation
11.8 Affymetrix Inc.
11.9 Perkinelmer, Inc.
11.10 Sigma-Aldrich Corp
Browse more reports on Proteomic Market @ http://www.rnrmarketresearch.com/reports/life-sciences/biotechnology/proteomic .
RnRMarketResearch.com is an online database of market research reports offer in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.